Kyowa Hakko's IMMUSE™, a research-backed postbiotic, provides immune support for travelers in this new innovative formula, "Well Traveled Immune Activator."
NEW YORK, April 12, 2023 /PRNewswire-PRWeb/ -- Avid traveler and Well Traveled founder Patrick Firlik knows firsthand how debilitating travel can be for the immune and digestive systems. Seven years working as a management consultant combined with a personal passion for exploring the world, meant Patrick was on the road a lot. He started Well Traveled to address the pain points he experienced while traveling.
"When I was away from home, my routines were disrupted, I was exposed to lots of germs, and sometimes stressed. As a result, I often found myself sick, dehydrated, tired, lacking focus, and not eating or sleeping well. I was far from my best and I was tired of using sugary, artificial products that were moderately effective. That's when I realized there had to be a better way to stay well on the road," comments Firlik, adding, "When working on this new endeavor, the number one priority was to make sure the products were clean and used clinically- researched ingredients, so I turned to nutrition experts to achieve the right formula," Firlik said.
Well Traveled Immune Activator is the first product of this exceptional wellness venture that aims to keep travelers well while on the road. It contains 50mg of IMMUSE™ LC-plasma, a postbiotic that proactively supports the immune system through a novel method of activation of pDC (plasmacytoid dendritic cells)*. The pDC, a rare type of immune cell, has been shown to activate pivotal cells, such as NK, Killer-T, Helper-T, and B cells, for a more comprehensive approach to immune support*. IMMUSE™ is backed by 30 published studies, including 15 human clinical trials and over 10 years of research. IMMUSE™ is supplied by Kyowa Hakko, an international ingredients manufacturer whose primary goal is to provide health solutions that support optimal health for improved quality of life.
"As we are all traveling more, supporting immune system health is more important than ever, and we are pleased to see our IMMUSE™ ingredient formulated into such an innovative supplement," commented Karen Todd, MBA, RD, Vice President Global Brand Marketing, Kyowa Hakko USA, Inc. "This is the first time that a brand is addressing the health needs of travelers in such a comprehensive way."
What makes Well Traveled Immune Activator so unique is the combination of postbiotic and prebiotic, IMMUSE™ and BeniCaros, which creates gut-mediated immune activation, a mechanism uncommon in the space. The result is a powerful, triple action effect that strengthens the body's natural defenses*, activates faster immune response*, and accelerates recovery*.
Traveling, especially by plane, causes adverse effects on the body, such as stress, dehydration, fatigue, bloating, and reduced blood flow. Well Traveled Immune Activator is a daily and convenient immune support supplement that helps the body combat these negative effects, a timely advantage now as the demand for business travel continues to build. According to the 2023 Traveler Values Index, about a third (32%) of consumers plan to take a business trip in the next 12 months, including more than 3 in 5 (62%) remote workers. This is a significant increase from April 2022, when only 16% of consumers said they would travel for business in the next 12 months. Not only are consumers planning to travel for work again, but 85% of business travelers also said they are excited to travel for work, opening up opportunities for brands like Well Traveled to serve travelers' health and wellness needs.
*The Food and Drug Administration has not evaluated these statements. This product is not intended to diagnose, treat, cure or prevent any disease.
Well Traveled Immune Activator with IMMUSE™ can be purchased on the Well Traveled website at https://www.gowelltraveled.com/.
To learn more about IMMUSE™, please visit: https://immusehealth.com/
Media interested in setting up an interview with Karen Todd, please get in touch with Giselle Chollett: at [email protected] or 917.386.7116.
About IMMUSE:
IMMUSE™ is a postbiotic that delivers a new, breakthrough approach to broad range immune support*. As a clinically researched immune activator* supported by 30 published studies, including 15 human trials, IMMUSE™ proactively supports the immune system through a novel method of action that activates pDC (plasmacytoid dendritic cells)*. The pDC, a rare type of immune cell, functions as a key leader of the immune system and has been shown to activate pivotal cells such as NK, Killer-T, Helper-T, and B cells, for a more comprehensive approach to immune support*. Its unique mechanism of action, discovered by Kyowa Hakko's parent company Kirin Holdings Co., Ltd., is opening doors for discovering postbiotics concerning immune health.
About Kyowa Hakko USA:
Kyowa Hakko USA is the North & South American office of Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development, manufacturing, and marketing pharmaceuticals, nutraceuticals, and food & beverage products. Kyowa is the maker of branded ingredients, including IMMUSE™ LC-Plasma, Eyemuse™ Lacticaseibacillus paracasei KW3110, Cognizin® Citicoline, Pantesin® Pantethine, Setria® Glutathione, as well as L-Alanyl-L-Glutamine. For more information, visit http://www.kyowa-usa.com.
About Well Traveled:
Well Traveled is reimagining travel wellness with clean, natural, and clinically-proven supplements for the modern traveler to stay well on the road. We address the many pain points of travelers, starting with immune support. Well Traveled is for those who enjoy the thrill of the road and exploring new places but prioritize their health and wellbeing. Learn more: https://gowelltraveled.com/
Media Contact
Maria Stanieich, Kyowa Hakko, 5514829968, [email protected]
SOURCE Kyowa Hakko
Share this article